Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 9/20 | 0.38 |
| ▸ | MEN1 | O00255 | 5/20 | 0.38 |
| ▸ | NPC1 | O15118 | 3/20 | 0.38 |
| ▸ | RAB9A | P51151 | 4/20 | 0.37 |
| ▸ | POLB | P06746 | 3/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7833221 | 0.82 | MAPK1 (0.57) | MAPK1HSD17B10KMT2AMEN1NPC1 | |
| SCHEMBL3805634 | 0.80 | MAPK1 (0.51) | MAPK1HSD17B10KMT2AMEN1NPC1 | |
| SCHEMBL8930247 | 0.77 | MAPK1 (0.60) | MAPK1HSD17B10KMT2AMEN1NPC1 | |
| SCHEMBL8930176 | 0.76 | MAPK1 (0.35) | MAPK1HSD17B10KMT2AMEN1NPC1 | |
| SCHEMBL8440916 | 0.74 | MAPK1 (0.47) | MAPK1HSD17B10KMT2AMEN1NPC1 | |
| SCHEMBL3767102 | 0.72 | MAPK1 (0.32) | MAPK1HSD17B10 | |
| SCHEMBL7596951 | 0.69 | MAPK1 (0.58) | MAPK1HSD17B10KMT2AMEN1NPC1 | |
| Carboxin SCHEMBL8819780 | 0.69 | MAPK1 (1.00) | MAPK1HSD17B10KMT2AMEN1NPC1 | |
| SCHEMBL17471577 | 0.68 | MAPK1 (0.57) | MAPK1HSD17B10KMT2ANPC1RAB9A | |
| SCHEMBL11375431 | 0.67 | MAPK1 (0.71) | MAPK1HSD17B10KMT2AMEN1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1509513-B1 | MICROBICIDAL OXATHIINCARBOXAMIDES | BAYER CROPSCIENCE AG (DE) | 2009-07-29 | — | — | EP | disclosed |
| EP-1509513-B1 | MICROBICIDAL OXATHIINCARBOXAMIDES | BAYER CROPSCIENCE AG (DE) | 2009-07-29 | — | — | EP | disclosed |
| US-7119049-B2 | Oxathiinecarboxamides | BAYER CROPSCIENCE AG (DE) | 2006-10-10 | — | — | US | disclosed |
| US-20050203171-A1 | Oxathiincarboxamides | BAYER CROPSCIENCE AG (DE) | 2005-09-15 | — | — | US | disclosed |
| EP-1509513-A1 | OXATHIINCARBOXAMIDES | Bayer CropScience AG (DE) | 2005-03-02 | — | — | EP | disclosed |
| WO-2003099804-A1 | OXATHIINCARBOXAMIDES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2003-12-04 | — | — | WO | disclosed |
| US-5693827-A | Treatment of HIV infections and compounds useful therein | UNIROYAL CHEMICAL COMPANY, INC. | 1997-12-02 | — | — | US | disclosed |
| EP-0497816-B1 | TREATMENT OF HIV INFECTIONS AND COMPOUNDS USEFUL THEREIN | UNIROYAL CHEMICAL LTD (CA) | 1995-05-17 | — | — | EP | disclosed |
| US-5268389-A | Containing a benzene ring | UNIROYAL CHEMICAL COMPANY, INC. (US) | 1993-12-07 | — | — | US | disclosed |
| EP-0497816-A1 | TREATMENT OF HIV INFECTIONS AND COMPOUNDS USEFUL THEREIN. | UNIROYAL CHEMICAL LTD (CA) | 1992-08-12 | — | — | EP | disclosed |
| US-5075488-A | Fungicides | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1991-12-24 | — | — | US | disclosed |
| EP-0128006-B1 | A SOIL-DISEASE-CONTROLLING AGENT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1991-09-18 | — | — | EP | disclosed |
| WO-1991005761-A1 | TREATMENT OF HIV INFECTIONS AND COMPOUNDS USEFUL THEREIN | UNIROYAL CHEMICAL LTD./UNIROYAL CHEMICAL LTEE (CA) | 1991-05-02 | — | — | WO | disclosed |
| US-4709052-A | FUNGICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1987-11-24 | — | — | US | disclosed |
| EP-0128006-A2 | A soil-disease-controlling agent | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1984-12-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050203171-A1 | Oxathiincarboxamides | MRPL21, ODC1, DDT | MAPK1 4217/4885HSD17B10 3440/4885KMT2A 1978/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.